Esperion

Performance

About Esperion

Esperion is a biopharmaceutical company focused on discovering, developing and commercializing innovative medicines to reduce cardiovascular risk. The company operates globally, leveraging commercial execution, international partnerships and collaborations to bring its therapies to patients. Its products target lipid management and cardiovascular disease, with a pipeline that includes ACLY biology and next-generation inhibitors. Esperion emphasizes science-driven approaches to advance cardiovascular health and address unmet medical needs.